Genmab A/S Current And Deferred Tax Relating To Items Charged Or Credited Directly To Equity
Genmab A/S (GNMSF) reported Current And Deferred Tax Relating To Items Charged Or Credited Directly To Equity of -$3.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:CurrentAndDeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity · last filed 2026-02-17
| Period end | Current And Deferred Tax Relating To Items Charged Or Credited Directly To Equity 12 month |
|---|---|
| 2025-12-31 | -$3.00M 20-F · filed 2026-02-17 |
| 2024-12-31 | $7.00M 20-F · filed 2026-02-17 |
| 2023-12-31 | $8.00M 20-F · filed 2026-02-17 |